Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centrosomal protein of 68 kDa (CEP68) is a structural protein encoded by the CEP68 gene in humans. It localizes to the centrosome and plays a critical role in maintaining centrosome cohesion by forming, together with rootletin, an extended filamentous network that links centrioles and prevents their premature splitting during interphase and mitosis[1][2][3][6][7][11]. CEP68 contains a C-terminal spectrin repeat domain that mediates its structural interactions, particularly with rootletin, essential for assembling the centrosome cohesion apparatus[2]. CEP68 dissociates from centrosomes during mitosis, suggesting dynamic regulation of its function in the cell cycle[1]. Mutations and dysregulation of CEP68 are associated with rare inherited diseases such as retinitis pigmentosa 28 and angioedema[3]. Although it is vital for centrosome structure and function, CEP68 is not considered a canonical therapeutic target, with no drugs or clinical biomarkers linked to its modulation as of now[3][6][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centrosomal protein of 68 kDa (CEP68).